Go
HomeASCP FoundationCCGPCalendarDiscussionContactStore
Join ASCP Earn CE Credit Develop Your Practice Explore Policy Issues Read All About It
About ASCP
Education & Meetings
Practice Resources
Government Affairs & Advocacy
Publications
Members
Students
Industry
Public
spacer
WMA Award
Advanced SearchSite Map
Government Affairs & Advocacy Section
Government Affairs & Advocacy Section picture
spacer
spacer
ASCP Midyear Conference '09
spacer
SeniorCarePharmacist.com
Senior Care Pharmacy ’07 - ASCP's 38th Annual Meeting and Exhibition

November 14-17
Pennsylvania Convention Center
Philadelphia, PA

Call for Proposals: Posters and Papers

Submission deadline 5/29/07
Notification deadline 7/6//07

Posters
The American Society of Consultant Pharmacists is seeking poster submissions that provide innovative ways to approach challenges to senior care pharmacists in a variety of long-term care settings.

Poster presentations will be held on Thursday, November 15 and Friday, November 16, 2007, during ASCP exhibit hours. They provide the presenting authors a forum to display their work and talk informally with attendees. Poster presenters are required to remain with their poster for the full three hours of the display.

Contributed Papers
The American Society of Consultant Pharmacists is seeking contributed paper presentations that will provide innovative ways to approach challenges pharmacists face in a variety of alternate site and long-term care settings. Authors of accepted contributed papers will be allotted approximately 15 minutes for presentation and questions (10 minutes for presentation and 5 minutes for questions and answers). A PowerPoint presentation is required.


Submission Areas
  • Research Reports
    Evaluative studies that report completed, original research on clinical drug studies, therapeutic issues, new services, or outcomes of services provided for the geriatric population.
  • Research-in-Progress
    Uncompleted evaluative studies that are currently in progress and will most likely still be in progress at the time of the Annual Meeting. Authors are required to have validated the study methods and describe preliminary results of research. Research-in-progress studies may address clinical drug studies, therapeutic issues, new roles or services, or outcomes of services provided for the geriatric population.
  • Descriptive Reports (Posters only)
    Descriptions of new, improved, or innovative activities or services that would be of interest to other practitioners. Descriptive reports do not need to include formal results, but should summarize outcome(s) of the program or service. This may include reports from ASCP State Chapters and affiliated organizations.
  • Encore Presentations (Posters only)
    Evaluative studies that have been presented at other meetings but contain information of interest and importance to pharmacists working with the geriatric population. Encore presentations must be completed, original research on clinical drug studies, therapeutic issues, new roles or services, or outcomes of services provided.
  • Practice and Management Evaluative Studies  (Papers only)                                                        Analysis of steps used in developing or implementing a new pharmacy system, service or program for customers and patients; resolving an administrative problem; or implementing a new management system or program. Presentations should include a case study of the new system, program, or change, and analyze and evaluate the outcome of the actions.

Submission Instructions
  1. Prepare an abstract, 250 words or less, according to the guidelines. Abstracts must not contain tables at the time of submission. Abstracts will be printed in the ASCP Annual Meeting program book and ASCP’s official journal, The Consultant Pharmacist. Abstracts must follow The Consultant Pharmacist Style Guide. Failure to follow these guidelines may jeopardize publication of the abstract.  A sample of an abstract is also included in this application.
  2. Complete all sections of the online application. If planning to submit more than one poster or paper for consideration, you must submit a separate application for each one. Be sure to read and understand the copyright release statement and the recording agreement included in the application.
  3. Applications can only be submitted electronically by using the link below.
  4. Incomplete or improperly formatted submissions will not be accepted.
  5. Deadline for submission is May 29, 2007 5:00 p.m. (Eastern time).
 
Guidelines for Posters or Contributed Papers

Titles
Capitalize all words in the title except articles, short prepositions (<4 letters), and conjunctions. (see example abstract)

Abstracts
The online submission form will prompt you to download your abstract file. Prepare your abstract as described here and save it as a word or text document before you start the online submission. All abstracts must be <250 words and submitted in the proper format.

Do not include the title or authors in the abstract. Begin each paragraph of the abstract with the headings described below.

Research and Evaluative Studies
Submissions should include the following:

       Purpose: The first paragraph concisely states the
       specific objectives or purpose of the study in one
       or two sentences.
       Methods: The second paragraph provides detailed                         information about the methods or procedures that were used        to conduct the study.
       Results: The third paragraph presents a broad summary of        the results, including specific data and statistics where                possible.
       Conclusions: The fourth paragraph concisely states the              principal outcomes of the study in one or two sentences.

Descriptive Reports (posters only)
Submissions should include the following:

       Purpose: The first paragraph concisely states the purpose or
       objective of the program or service in one or two sentences.
       Include the problem or situation which prompted the                program or service to be implemented.
       Methods: The second paragraph provides information about        the methods or procedures that were used to implement the
       program or service.
       Outcomes: The third paragraph concisely states the                    principal outcome(s) of the program or service and how it            was received in one or two sentences.
 
Sample Abstract of a Research Report
Similarities and Differences in the Medication Profiles of an Elderly Ambulatory Care Patient Population With Gastroenterologic and Rheumatologic Disorders
Kay L. Brooks, Janice L. Feinberg, and Thomas R. Clark

Purpose: The frequency of multiple medication use in an elderly outpatient population with gastroenterologic and rheumatologic disease was determined through a retrospective review of pharmacy records.

Methods: The study population was comprised of 60 men (age range 30-80 years) with gastroenterologic disorders and 50 men (age range 33-75 years) with rheumatologic disorders who visited a Veterans Administration Hospital. The medications prescribed for these patients were classified according to pharmacotherapeutic categories in American Hospital Formulary Service, Drug Information 1990.

Results: During a one-year period, 573 medications were prescribed for the gastroenterologic patients and 452 medications were prescribed for the rheumatologic patients (average, 9 medications per patient). The three classes of medications prescribed most frequently for gastroenterologic patients (in descending order of frequency) were gastrointestinal agents, central nervous system agents, and cardiovascular agents. For rheumatologic patients, the classes were the same but the order was central nervous system agents, cardiovascular agents, and gastrointestinal agents. Medication in these three categories represented 53.6% of total medications for gastroenterologic patients and 59% of total medications for rheumatologic patients.

Conclusions: Although the number of medications increased as the number of physician visits increased, no relationship was found between the number of diagnosed disorders and the number of prescribed medications. The number of actual drug interactions found was minimal.


Incomplete or improperly formatted submissions will not be accepted.

Copyright Release

Posters and contributed papers are received with the understanding that they have not been published. Encore presentations are received with the understanding that they have been published only in abstract form.

Author Affiliation/Financial or In-Kind Support
ASCP is committed to provide attendees with posters that are of high quality and balanced content. Authors are asked to disclose affiliation and financial or in-kind support on the submission and poster itself. For example, in-kind support is defined as any administrative assistance, statistical support, or materials donated to assist research. Pharmaceutical industry initiated poster content will be presented separately at the meeting on Friday, November 16, 2007. Pharmaceutical industry employees may be co-authors if they participated in the research, but may not be the sole presenter at the poster.


 
The Consultant Pharmacist Style Guide
Failure to follow these guidelines may jeopardize publication of the abstract in the journal. All abstracts will be edited to conform to journal style.

Abbreviations: Except for specific abbreviations, spell out words on first reference, followed by the abbreviation in parentheses. Avoid awkward constructions that place the second abbreviation close to the first reference. All acronyms MUST be spelled out on first reference, including the names of clinical trials. Scientific or medical abbreviations must be spelled out (e.g. "every day" instead of "QD" and "as needed" instead of "PRN").

Bulleted lists: Capitalize first word of each item; don't use semicolons or commas at the end of each bullet, or end the second to last bullet with "and"; use a period if each bullet is a full sentence.

Citations and References: For the citation for The Consultant Pharmacist at the end of the abstract in peer-reviewed articles. Be careful to note the spacing (or lack of spacing):

Consult Pharm 1997;12:148–52.

For other references:

Jones GA, Smith LE, Webster RT et al. Interaction of phenytoin with nutrients. Clin Pharm 1986;5:118-23.

Hogan RC. Pesonality testing instruments. In: Dunnette M, Webster RT, eds. Handbook of industrial psychology. Palo Alto, CA: Psychology Press; 1995.

For up to three authors, all are named; more than three, list three and then et al., as in the example above. Note: no comma and a single period for “et al.”
  •  Titles of referenced articles are all lower case except for the first letter, and end with a period.
  • List the abbreviated journal name in caps and lower case and the year. A list of journal abbreviations can be obtained from the National Library of Medicine.
  • For citations, the year is followed by a semicolon, a space, then the volume number, a colon, and the page range, with no spaces, ending with a period.
  • For the page range, list the beginning page, an en-dash, and the ending page of the article; list only the digits that change in the ending page number.
Colon, semicolon: Simple lists following a colon are separated by commas, not semicolons. The use of semicolons following colons is reserved for cases where clauses are very long, or are themselves subdivided by commas.

If the element introduced by the colon consists of more than one sentence each referring to the statement before the colon, or if it is a formal statement, a quotation, or a speech in dialogue, it should be capitalized. Otherwise, it will begin with a lower case letter. See Chicago for detailed style guidelines.

Commas: Always placed inside quotes, including single quotes inside double quotes.

Hyphens: In non-scientific material, use “to” to separate numbers in a range, such as “10 to 20 days.” In scientific material, use an en-dash: 1–2 mg (for abbreviations), and 10.5%–11.5% (for symbols).
Print PagePrint Page  Email PageEmail Page 
Copyright & DisclaimerPrivacy StatementGuidelines
#Email Address